Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review

Janine T Hidding, Carien H G Beurskens, Philip J van der Wees, Hanneke W M van Laarhoven, Maria W G Nijhuis-van der Sanden, Janine T Hidding, Carien H G Beurskens, Philip J van der Wees, Hanneke W M van Laarhoven, Maria W G Nijhuis-van der Sanden

Abstract

Background: Breast cancer is the most common type of cancer in women in the developed world. As a result of breast cancer treatment, many patients suffer from serious complaints in their arm and shoulder, leading to limitations in activities of daily living and participation. In this systematic literature review we present an overview of the adverse effects of the integrated breast cancer treatment related to impairment in functions and structures in the upper extremity and upper body and limitations in daily activities. Patients at highest risk were defined.

Methods and findings: We conducted a systematic literature search using the databases of PubMed, Embase, CINAHL and Cochrane from 2000 to October 2012, according to the PRISMA guidelines. Included were studies with patients with stage I-III breast cancer, treated with surgery and additional treatments (radiotherapy, chemotherapy and hormonal therapy). The following health outcomes were extracted: reduced joint mobility, reduced muscle strength, pain, lymphedema and limitations in daily activities. Outcomes were divided in within the first 12 months and >12 months post-operatively. Patients treated with ALND are at the highest risk of developing impairments of the arm and shoulder. Reduced ROM and muscle strength, pain, lymphedema and decreased degree of activities in daily living were reported most frequently in relation to ALND. Lumpectomy was related to a decline in the level of activities of daily living. Radiotherapy and hormonal therapy were the main risk factors for pain.

Conclusions: Patients treated with ALND require special attention to detect and consequently address impairments in the arm and shoulder. Patients with pain should be monitored carefully, because pain limits the degree of daily activities. Future research has to describe a complete overview of the medical treatment and analyze outcome in relation to the treatment. Utilization of uniform validated measurement instruments has to be encouraged.

Conflict of interest statement

Competing Interests: No authors have any competing interests.

Figures

Figure 1. Flow diagram literature search adverse…
Figure 1. Flow diagram literature search adverse effects of breast cancer treatment.

References

    1. Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, et al. (2009) The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol 16: 1959–1972.
    1. Rietman JS, Geertzen JH, Hoekstra HJ, Baas P, Dolsma WV, et al. (2006) Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol 32: 148–152.
    1. Land SR, Kopec JA, Julian TB, Brown AM, Anderson SJ, et al. (2010) Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32. J Clin Oncol 28: 3929–3936.
    1. Schmitz KH, Prosnitz RG, Schwartz AL, Carver JR (2012) Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors. Cancer 118: 2270–2276.
    1. McNeely ML, Campbell K, Ospina M, Rowe BH, Dabbs K, et al. (2010) Exercise interventions for upper-limb dysfunction due to breast cancer treatment. Cochrane Database Syst Rev: CD005211.
    1. Stout NL, Pfalzer LA, Springer B, Levy E, McGarvey CL, et al. (2012) Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Physical Therapy 92: 152–163.
    1. Cheville AL, Tchou J (2007) Barriers to rehabilitation following surgery for primary breast cancer. Journal of surgical oncology 95: 409–418.
    1. WHO-FIC website. Available: . Accessed 2013 Jun 19.
    1. CEBM website. Available: . Accessed 2012 Feb 15.
    1. Hayes S, Speck R, Reimet E, Stark A, Schmitz K (2011) Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial. Breast Cancer Res Treat: 227–234.
    1. Zhou WB, Zhang PL, Liu XA, Yang T, He W (2011) Innegligible musculoskeletal disorders caused by zoledronic acid in adjuvant breast cancer treatment: a meta-analysis. J Exp Clin Cancer Res 30: 72.
    1. Liu CQ, Guo Y, Shi JY, Sheng Y (2009) Late morbidity associated with a tumour-negative sentinel lymph node biopsy in primary breast cancer patients: a systematic review. Eur J Cancer 45: 1560–1568.
    1. Levangie PK, Drouin J (2009) Magnitude of late effects of breast cancer treatments on shoulder function: a systematic review. Breast Cancer Res Treat 116: 1–15.
    1. Moja L, Tagliabue L, Balduzzi S, Parmelli E, Pistotti V, et al. (2012) Trastuzumab containing regimens for early breast cancer. Cochrane Database Syst Rev.
    1. Lee TS, Kilbreath SL, Refshauge KM, Herbert RD, Beith JM (2008) Prognosis of the upper limb following surgery and radiation for breast cancer. Breast Cancer Res Treat 110: 19–37.
    1. Paskett ED, Naughton MJ, McCoy TP, Case LD, Abbott JM (2007) The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev 16: 775–782.
    1. Ververs JM, Roumen RM, Vingerhoets AJ, Vreugdenhil G, Coebergh JW, et al. (2001) Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. European journal of cancer 37: 991–999.
    1. Ozcinar B, Guler SA, Kocaman N, Ozkan M, Gulluoglu BM, et al. (2012) Breast cancer related lymphedema in patients with different loco-regional treatments. Breast 21: 361–365.
    1. Wernicke AG, Goodman RL, Turner BC, Komarnicky LT, Curran WJ, et al. (2011) A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance. Breast Cancer Res Treat 125: 893–902.
    1. Park JH, Lee WH, Chung HS (2008) Incidence and risk factors of breast cancer lymphoedema. J Clin Nurs 17: 1450–1459.
    1. Kwan ML, Darbinian J, Schmitz KH, Citron R, Partee P, et al. (2010) Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study. Arch Surg 145: 1055–1063.
    1. Kanematsu M, Morimoto M, Honda J, Nagao T, Nakagawa M, et al. (2011) The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia. BMC Cancer 11: 436.
    1. Yen TW, Fan X, Sparapani R, Laud PW, Walker AP, et al. (2009) A contemporary, population-based study of lymphedema risk factors in older women with breast cancer. Ann Surg Oncol 16: 979–988.
    1. Mieog JS, Morden JP, Bliss JM, Coombes RC, van de Velde CJ, et al. (2012) Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2–3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study. Lancet Oncol 13: 420–432.
    1. Chang DW, Kim S (2010) Breast reconstruction and lymphedema. Plast Reconstr Surg 125: 19–23.
    1. Norman SA, Localio AR, Kallan MJ, Weber AL, Torpey HA, et al. (2010) Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev 19: 2734–2746.
    1. Lundstedt D, Gustafsson M, Steineck G, Alsadius D, Sundberg A, et al. (2012) Long-term symptoms after radiotherapy of supraclavicular lymph nodes in breast cancer patients. Radiother Oncol 103: 155–160.
    1. Taira N, Shimozuma K, Shiroiwa T, Ohsumi S, Kuroi K, et al. (2011) Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery. Breast Cancer Res Treat 128: 235–247.
    1. Bevilacqua JL, Kattan MW, Changhong Y, Koifman S, Mattos IE, et al. (2012) Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer. Ann Surg Oncol 19: 2580–2589.
    1. Mak SS, Yeo W, Lee YM, Mo KF, Tse KY, et al. (2008) Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong. Nurs Res 57: 416–425.
    1. Rief W, Bardwell WA, Dimsdale JE, Natarajan L, Flatt SW, et al. (2011) Long-term course of pain in breast cancer survivors: a 4-year longitudinal study. Breast Cancer Res Treat 130: 579–586.
    1. Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, et al. (2010) Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 102: 111–118.
    1. Levy EW, Pfalzer LA, Danoff J, Springer BA, McGarvey C, et al. (2012) Predictors of functional shoulder recovery at 1 and 12 months after breast cancer surgery. Breast Cancer Res Treat 134: 315–324.
    1. Nesvold IL, Reinertsen KV, Fossa SD, Dahl AA (2011) The relation between arm/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study. J Cancer Surviv 5: 62–72.
    1. Dahl AA, Nesvold IL, Reinertsen KV, Fossa SD (2011) Arm/shoulder problems and insomnia symptoms in breast cancer survivors: cross-sectional, controlled and longitudinal observations. Sleep Med 12: 584–590.
    1. Hickey BE, Francis DP, Lehman M (2013) Sequencing of chemotherapy and radiotherapy for early breast cancer. Cochrane Database Syst Rev 4: CD005212.
    1. Shamley D, Srinaganathan R, Oskrochi R, Lascurain-Aguirrebena I, Sugden E (2009) Three-dimensional scapulothoracic motion following treatment for breast cancer. Breast Cancer Res Treat 118: 315–322.
    1. Andersen KG, Jensen MB, Kehlet H, Gärtner R, Eckhoff L, et al. (2012) Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide. Acta Oncol 51: 1036–1044.
    1. Sagen A, Kåresen R, Sandvik L, Risberg MA (2009) Changes in arm morbidities and health-related quality of life after breast cancer surgery - a five-year follow-up study. Acta Oncol 48: 1111–1118.
    1. Sheridan D, Foo I, O'Shea H, Gillanders D, Williams L, et al. (2012) Long-term follow-up of pain and emotional characteristics of women after surgery for breast cancer. J Pain Symptom Manage 44: 608–614.
    1. Johnsson A, Fornander T, Rutqvist LE, Olsson M (2010) Factors influencing return to work: a narrative study of women treated for breast cancer. Eur J Cancer Care (Engl) 19: 317–323.
    1. Avraham T, Daluvoy SV, Riedel ER, Cordeiro PG, Van Zee KJ, et al. (2010) Tissue expander breast reconstruction is not associated with an increased risk of lymphedema. Annals of surgical oncology 17: 2926–2932.
    1. Miller CL, Specht MC, Skolny MN, Jammallo LS, Horick N, et al. (2012) Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: implications for prophylactic surgery. Breast Cancer Res Treat 135: 781–789.
    1. Ridner SH, Dietrich MS, Stewart BR, Armer JM (2011) Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer 19: 853–857.
    1. Yang EJ, Park WB, Seo KS, Kim SW, Heo CY, et al. (2010) Longitudinal change of treatment-related upper limb dysfunction and its impact on late dysfunction in breast cancer survivors: a prospective cohort study. J Surg Oncol 101: 84–91.
    1. Devoogdt N, Van Kampen M, Geraerts I, Coremans T, Fieuws S, et al. (2010) Physical activity levels after treatment for breast cancer: one-year follow-up. Breast Cancer Res Treat 123: 417–425.
    1. Beurskens CHG, Uden van CJT, Strobbe LJA, Oostendorp RAB, Wobbes T (2007) The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study. BMC Cancer 166–173.
    1. Khan AJ, Arthur D, Vicini F, Beitsch P, Kuerer H, et al. (2012) Six-year analysis of treatment-related toxicities in patients treated with accelerated partial breast irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy registry trial. Ann Surg Oncol 19: 1477–1483.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever